Integrated Genomic Analysis of Diverse Induced Pluripotent Stem Cells from the Progenitor Cell Biology Consortium

Stem Cell Reports

Volumn 7, Issue 1, 2016, Pages 110-125

  Salomonis, Nathan ^a   Dexheimer, Phillip J ^a   Omberg, Larsson ^b   Schroll, Robin ^a   Bush, Stacy ^a   Huo, Jeffrey ^c,d   Schriml, Lynn ^e   Ho Sui, Shannan ^f,g   Keddache, Mehdi ^a   Mayhew, Christopher ^a   Shanmukhappa, Shiva Kumar ^a   Wells, James ^a   Daily, Kenneth ^b   Hubler, Shane ^b   Wang, Yuliang ^h   Zambidis, Elias ^c,d   Margolin, Adam ^b,h   Hide, Winston ^f,g,i   Hatzopoulos, Antonis K ^j   Malik, Punam ^a   Cancelas, Jose A ^a,k   Aronow, Bruce J ^a   Lutzko, Carolyn ^a,k   more..

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b SAGE BIONETWORKS   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g HARVARD STEM CELL INSTITUTE   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF SHEFFIELD   (United Kingdom)

^j VANDERBILT UNIVERSITY   (United States)

^k UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL SCREENING; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA METHYLATION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; INDUCED PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SEX DIFFERENCE; STEM CELL SELF-RENEWAL; X CHROMOSOME INACTIVATION; GENETICS; GENOMICS; HUMAN GENOME; METABOLISM; NUCLEAR REPROGRAMMING; STEM CELL;

CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; DNA METHYLATION; GENE EXPRESSION; GENOME, HUMAN; GENOMICS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; STEM CELLS;

EID: 84992166098     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2016.05.006     Document Type: Article

References (36)

1. Abyzov, A., Mariani, J., Palejev, D., Zhang, Y., Haney, M.S., Tomasini, L., Ferrandino, A.F., Rosenberg Belmaker, L.A., Szekely, A., Wilson, M., et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492 (2012), 438–442.
2. Aryee, M.J., Jaffe, A.E., Corrada-Bravo, H., Ladd-Acosta, C., Feinberg, A.P., Hansen, K.D., Irizarry, R.A., Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30 (2014), 1363–1369.
3. Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z.D., Ziller, M., Croft, G.F., Amoroso, M.W., Oakley, D.H., et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144 (2011), 439–452.
4. Chen, J., Bardes, E.E., Aronow, B.J., Jegga, A.G., ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 37 (2009), W305–W311.
5. Cheng, B., Ren, X., Kerppola, T.K., KAP1 represses differentiation-inducible genes in embryonic stem cells through cooperative binding with PRC1 and derepresses pluripotency-associated genes. Mol. Cell. Biol. 34 (2014), 2075–2091.
6. Clancy, J.L., Patel, H.R., Hussein, S.M., Tonge, P.D., Cloonan, N., Corso, A.J., Li, M., Lee, D.S., Shin, J.Y., Wong, J.J., et al. Small RNA changes en route to distinct cellular states of induced pluripotency. Nat. Commun., 5, 2014, 5522.
7. Cunningham, J.J., Ulbright, T.M., Pera, M.F., Looijenga, L.H., Lessons from human teratomas to guide development of safe stem cell therapies. Nat. Biotechnol. 30 (2012), 849–857.
8. Emig, D., Salomonis, N., Baumbach, J., Lengauer, T., Conklin, B.R., Albrecht, M., AltAnalyze and DomainGraph: analyzing and visualizing exon expression data. Nucleic Acids Res. 38 (2010), W755–W762.
9. Encode Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489 (2012), 57–74.
10. Gopalakrishna-Pillai, S., Iverson, L.E., A DNMT3B alternatively spliced exon and encoded peptide are novel biomarkers of human pluripotent stem cells. PLoS One, 6, 2011, e20663.
11. Hall, L.L., Byron, M., Butler, J., Becker, K.A., Nelson, A., Amit, M., Itskovitz-Eldor, J., Stein, J., Stein, G., Ware, C., et al. X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. J. Cell. Physiol. 216 (2008), 445–452.
12. International Stem Cell Initiative, Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., Amit, M., Andrews, P.W., Beighton, G., Bello, P.A., Benvenisty, N., Berry, L.S., et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25 (2007), 803–816.
13. Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., Salzberg, S.L., TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol., 14, 2013, R36.
14. Lee, D.S., Shin, J.Y., Tonge, P.D., Puri, M.C., Lee, S., Park, H., Lee, W.C., Hussein, S.M., Bleazard, T., Yun, J.Y., et al. An epigenomic roadmap to induced pluripotency reveals DNA methylation as a reprogramming modulator. Nat. Commun., 5, 2014, 5619.
15. Lu, Y., Loh, Y.H., Li, H., Cesana, M., Ficarro, S.B., Parikh, J.R., Salomonis, N., Toh, C.X., Andreadis, S.T., Luckey, C.J., et al. Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. Cell Stem Cell 15 (2014), 92–101.
16. Ma, H., Morey, R., O'Neil, R.C., He, Y., Daughtry, B., Schultz, M.D., Hariharan, M., Nery, J.R., Castanon, R., Sabatini, K., et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature 511 (2014), 177–183.
17. McConnell, M.J., Lindberg, M.R., Brennand, K.J., Piper, J.C., Voet, T., Cowing-Zitron, C., Shumilina, S., Lasken, R.S., Vermeesch, J.R., Hall, I.M., et al. Mosaic copy number variation in human neurons. Science 342 (2013), 632–637.
18. Mekhoubad, S., Bock, C., de Boer, A.S., Kiskinis, E., Meissner, A., Eggan, K., Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 10 (2012), 595–609.
19. Muller, F.J., Goldmann, J., Loser, P., Loring, J.F., A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell 6 (2010), 412–414.
20. Müller, F.J., Schuldt, B.M., Williams, R., Mason, D., Altun, G., Papapetrou, E.P., Danner, S., Goldmann, J.E., Herbst, A., Schmidt, N.O., et al. A bioinformatic assay for pluripotency in human cells. Nat. Methods 8 (2011), 315–317.
21. Nazor, K.L., Altun, G., Lynch, C., Tran, H., Harness, J.V., Slavin, I., Garitaonandia, I., Muller, F.J., Wang, Y.C., Boscolo, F.S., et al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 10 (2012), 620–634.
22. Nguyen, H.T., Geens, M., Mertzanidou, A., Jacobs, K., Heirman, C., Breckpot, K., Spits, C., Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL. Mol. Hum. Reprod. 20 (2014), 168–177.
23. Omberg, L., Ellrott, K., Yuan, Y., Kandoth, C., Wong, C., Kellen, M.R., Friend, S.H., Stuart, J., Liang, H., Margolin, A.A., Enabling transparent and collaborative computational analysis of 12 tumor types within the Cancer Genome Atlas. Nat. Genet. 45 (2013), 1121–1126.
24. Osborne, M.J., Volpon, L., Kornblatt, J.A., Culjkovic-Kraljacic, B., Baguet, A., Borden, K.L., eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition. Proc. Natl. Acad. Sci. USA 110 (2013), 3877–3882.
25. Rosenbloom, K.R., Armstrong, J., Barber, G.P., Casper, J., Clawson, H., Diekhans, M., Dreszer, T.R., Fujita, P.A., Guruvadoo, L., Haeussler, M., et al. The UCSC Genome Browser database: 2015 update. Nucleic Acids Res. 43 (2014), D670–D681.
26. Rouhani, F., Kumasaka, N., de Brito, M.C., Bradley, A., Vallier, L., Gaffney, D., Genetic background drives transcriptional variation in human induced pluripotent stem cells. PLoS Genet., 10, 2014, e1004432.
27. Salomonis, N., Nelson, B., Vranizan, K., Pico, A.R., Hanspers, K., Kuchinsky, A., Ta, L., Mercola, M., Conklin, B.R., Alternative splicing in the differentiation of human embryonic stem cells into cardiac precursors. PLoS Comput. Biol., 5, 2009, e1000553.
28. Schlaeger, T.M., Daheron, L., Brickler, T.R., Entwisle, S., Chan, K., Cianci, A., DeVine, A., Ettenger, A., Fitzgerald, K., Godfrey, M., et al. A comparison of non-integrating reprogramming methods. Nat. Biotechnol. 33 (2015), 58–63.
29. Silva, S.S., Rowntree, R.K., Mekhoubad, S., Lee, J.T., X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc. Natl. Acad. Sci. USA 105 (2008), 4820–4825.
30. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006), 663–676.
31. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., Jones, J.M., Embryonic stem cell lines derived from human blastocysts. Science 282 (1998), 1145–1147.
32. Tonge, P.D., Corso, A.J., Monetti, C., Hussein, S.M., Puri, M.C., Michael, I.P., Li, M., Lee, D.S., Mar, J.C., Cloonan, N., et al. Divergent reprogramming routes lead to alternative stem-cell states. Nature 516 (2014), 192–197.
33. Vallot, C., Ouimette, J.F., Makhlouf, M., Feraud, O., Pontis, J., Come, J., Martinat, C., Bennaceur-Griscelli, A., Lalande, M., Rougeulle, C., Erosion of X chromosome inactivation in human pluripotent cells initiates with XACT coating and depends on a specific heterochromatin landscape. Cell Stem Cell 16 (2015), 533–546.
34. Wang, W.C., Lin, F.M., Chang, W.C., Lin, K.Y., Huang, H.D., Lin, N.S., miRExpress: analyzing high-throughput sequencing data for profiling microRNA expression. BMC Bioinformatics, 10, 2009, 328.
35. Yan, L., Yang, M., Guo, H., Yang, L., Wu, J., Li, R., Liu, P., Lian, Y., Zheng, X., Yan, J., et al. Single-cell RNA-seq profiling of human preimplantation embryos and embryonic stem cells. Nat. Struct. Mol. Biol. 20 (2013), 1131–1139.
36. Young, M.A., Larson, D.E., Sun, C.W., George, D.R., Ding, L., Miller, C.A., Lin, L., Pawlik, K.M., Chen, K., Fan, X., et al. Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell 10 (2012), 570–582.